Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

rivastigmine 1.5 MG Oral Capsule

Known as: rivastigmine 1.5 MG (as rivastigmine tartrate 2.4 MG) Oral Capsule, RIVASTIGMINE TARTRATE 1.5 mg ORAL CAPSULE [Rivastigmine Tartrate], RIVASTIGMINE TARTRATE 1.5MG CAP,UD 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A series of new benzene-based derivatives was designed, synthesized and comprehensively characterized. All of the tested… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 3
Is this relevant?
2013
2013
Background: Cognitive decline has been recognised as a frequent symptom in multiple sclerosis (MS). Cholinesterase inhibitors… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2010
2010
OBJECTIVES Since January 2008 in The Netherlands, two cholinesterase inhibitors, oral galantamine and rivastigmine transdermal… Expand
Is this relevant?
2010
2010
SamenvattingDoel van onderzoek In Nederland zijn vanaf januari 2008 twee eenmaaldaags toe te dienen cholinesteraseremmers… Expand
Is this relevant?
2007
2007
Purpose[123I]FP-CIT SPECT is a valuable diagnostic tool to discriminate Lewy body dementia from Alzheimer’s dementia. To date… Expand
  • figure 1
Is this relevant?
2003
2003
Summary. Centrally acting cholinesterase inhibitors (ChEIs) improve cognitive functions in Alzheimer's disease (AD) and other… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2001
2001
Centrally acting cholinesterase inhibitors (ChEls) improve cognitive functions in Alzheimer's disease (AD) and other forms of… Expand
Is this relevant?
2001
2001
  • 2001
  • Corpus ID: 195121149
 
Is this relevant?
2001
2001
  • 2001
  • Corpus ID: 195150540
 
Is this relevant?